Locke Kenneth Thomas bought PROK
July 1, 2026 · Form 4 insider transaction
Locke Kenneth Thomas bought 750,000 shares of ProKidney Corp. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
750,000
Price
$0.00
Total value
N/A
InsiderLocke Kenneth Thomas
RoleOfficer
CompanyProKidney Corp. (PROK)
SecurityEmployee stock option (right to buy)
Transaction codeA: Grant or award
Transaction dateJuly 1, 2026
Filing dateJuly 6, 2026
Shares owned after750,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vests 25% on 1st anniversary of July 1, 2026 and the remaining 75% vests in substantially equal monthly installments for 36 months thereafter, subject to continued employment.